Immune Activation Mediated Change in Alpha-1-Acid Glycoprotein: Impact on Total and Free Lopinavir Plasma Exposure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Activation Mediated Change in Alpha-1-Acid Glycoprotein: Impact on Total and Free Lopinavir Plasma Exposure

Published:2011-11 Issue:11 Volume:51 Page:1539-1548
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Ofotokun Ighovwerha,Lennox Jeffrey L.,Eaton Molly E.,Ritchie James C.,Easley Kirk A.,Masalovich Svetlana E.,Long Mary C.,Acosta Edward P.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270010385118/fullpdf

Reference29 articles.

1. Virological, intracellular, and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study);Breilh;AIDS,2004

2. Concentration-controlled compared with conventional antiretroviral therapy for HIV infection;Fletcher;AIDS,2002

3. Pharmacologic optimization of protease inhibitors and nonnucleoside reverse transcriptase inhibitors (POPIN)-a randomized controlled trial of therapeutic drug monitoring and adherence support;Khoo;J Acquir Immune Defic Syndr,2006

4. Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients;Masquelier;Antimicrob Agents Chemother,2002

5. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients;Monforte;AIDS,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19 – Final results from the DisCoVeRy trial;2022-02-21

2. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19;Clinical Microbiology and Infection;2021-12

3. Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation?;Pharmaceutics;2021-11-19

4. Scoping insight on antiviral drugs against COVID-19;Arabian Journal of Chemistry;2021-10

5. Inflammation Suppresses Patients’ Ability to Metabolize Cytochrome P450 Substrate Drugs;Annals of Pharmacotherapy;2021-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3